메뉴 건너뛰기




Volumn 10, Issue 3, 2007, Pages 467-472

Hydrocodone use and sensorineural hearing loss

Author keywords

Cochlear implant; Hydrocodone; Sensorineural hearing loss

Indexed keywords

HYDROCODONE BITARTRATE PLUS PARACETAMOL; STEROID;

EID: 34250830285     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (57)

References (21)
  • 1
    • 33344461525 scopus 로고    scopus 로고
    • Ambulatory care visits to physician offices, hospital outpatient departments, and emergercy departments: United States, 2001-02
    • Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergercy departments: United States, 2001-02. Vital Health Stat 13 2006; 1-66.
    • (2006) Vital Health Stat , vol.13 , pp. 1-66
    • Schappert, S.M.1    Burt, C.W.2
  • 2
    • 25844526549 scopus 로고    scopus 로고
    • Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004
    • Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6:662-672.
    • (2005) J Pain , vol.6 , pp. 662-672
    • Cicero, T.J.1    Inciardi, J.A.2    Munoz, A.3
  • 3
    • 0034720813 scopus 로고    scopus 로고
    • Deafness associated with abuse of hydrocodone/acetaminophen
    • Oh AK, Ishiyama A, Baloh RW. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology 2000; 54:2345.
    • (2000) Neurology , vol.54 , pp. 2345
    • Oh, A.K.1    Ishiyama, A.2    Baloh, R.W.3
  • 4
    • 0034010931 scopus 로고    scopus 로고
    • Profound hearing loss associated with hydrocodone/acetaminophen abuse
    • Friedman RA, House JW, Luxford WM, Gherini S, Mills D. Profound hearing loss associated with hydrocodone/acetaminophen abuse. Am J Otol 2000; 21:188-191.
    • (2000) Am J Otol , vol.21 , pp. 188-191
    • Friedman, R.A.1    House, J.W.2    Luxford, W.M.3    Gherini, S.4    Mills, D.5
  • 5
    • 0025909040 scopus 로고
    • Complete nerve deafness after abuse of co-proxamol
    • Ramsey BC. Complete nerve deafness after abuse of co-proxamol. Lancet 1991; 338:446-447.
    • (1991) Lancet , vol.338 , pp. 446-447
    • Ramsey, B.C.1
  • 6
    • 0018017235 scopus 로고
    • Total deafness with chronic propoxyphene abuse
    • Harell M, Shea JJ, Emmett JR. Total deafness with chronic propoxyphene abuse. Laryngoscope 1978; 88:1518-1521.
    • (1978) Laryngoscope , vol.88 , pp. 1518-1521
    • Harell, M.1    Shea, J.J.2    Emmett, J.R.3
  • 7
    • 0017297269 scopus 로고
    • Inner ear damage related to propoxyphene ingestion
    • Lupin AJHS. Inner ear damage related to propoxyphene ingestion. Can Med Assoc J 1976; 114:596.
    • (1976) Can Med Assoc J , vol.114 , pp. 596
    • Lupin, A.J.H.S.1
  • 10
    • 0021246193 scopus 로고
    • Sudden hearing loss: Eight years' experience and suggested prognostic table
    • Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984; 94(5 Pt 1):647-661.
    • (1984) Laryngoscope , vol.94 , Issue.5 PART 1 , pp. 647-661
    • Byl Jr., F.M.1
  • 11
    • 0016927144 scopus 로고
    • Sudden sensorineural hearing impairment: A report of 1,220 cases
    • Shaia FT, Sheehy JL. Sudden sensorineural hearing impairment: a report of 1,220 cases. Laryngoscope. 1976; 86(3):389-398.
    • (1976) Laryngoscope , vol.86 , Issue.3 , pp. 389-398
    • Shaia, F.T.1    Sheehy, J.L.2
  • 12
    • 0037115525 scopus 로고    scopus 로고
    • Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs
    • Rogers JF, Nafziger AN, Bertino IS, Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med 2002; 113:746-750.
    • (2002) Am J Med , vol.113 , pp. 746-750
    • Rogers, J.F.1    Nafziger, A.N.2    Bertino Jr., I.S.3
  • 13
    • 0025853291 scopus 로고
    • Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers
    • Chen ZR, Somogyi AA, Reynolds G, Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol 1991; 31:381-390.
    • (1991) Br J Clin Pharmacol , vol.31 , pp. 381-390
    • Chen, Z.R.1    Somogyi, A.A.2    Reynolds, G.3    Bochner, F.4
  • 14
    • 0025830147 scopus 로고
    • Mu receptor binding of some commonly used opioids and their metabolites
    • Chen ZR, Irvine RJ, Somogyi AA, Bochner F. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 1991; 48:2165-2171.
    • (1991) Life Sci , vol.48 , pp. 2165-2171
    • Chen, Z.R.1    Irvine, R.J.2    Somogyi, A.A.3    Bochner, F.4
  • 15
    • 1542359666 scopus 로고    scopus 로고
    • CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes
    • Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol 2004; 57:287-297.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 287-297
    • Hutchinson, M.R.1    Menelaou, A.2    Foster, D.J.3    Coller, J.K.4    Somogyi, A.A.5
  • 16
    • 0036825844 scopus 로고    scopus 로고
    • Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: Genotyping cytochrome P450 2D6 for oxycodone cases
    • Jannetto PJ, Wong SH, Gock SB, Laleli-Sahin E, Schur BC, Jentzen JM. Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. J Anal Toxicol 2002:26:438-447.
    • (2002) J Anal Toxicol , vol.26 , pp. 438-447
    • Jannetto, P.J.1    Wong, S.H.2    Gock, S.B.3    Laleli-Sahin, E.4    Schur, B.C.5    Jentzen, J.M.6
  • 17
    • 0042634370 scopus 로고    scopus 로고
    • Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
    • de Leon J, Dinsmore L, Wedlund P. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol 2003; 23:420-421.
    • (2003) J Clin Psychopharmacol , vol.23 , pp. 420-421
    • de Leon, J.1    Dinsmore, L.2    Wedlund, P.3
  • 18
    • 1942469598 scopus 로고    scopus 로고
    • Characterization of the acetaminophen-induced degradation of cytochrome P450-3A4 and the proteolytic pathway
    • Zhang QX, Melnikov Z, Feierman DE. Characterization of the acetaminophen-induced degradation of cytochrome P450-3A4 and the proteolytic pathway. Basic Clin Pharmacol Toxicol 2004; 94:191-200.
    • (2004) Basic Clin Pharmacol Toxicol , vol.94 , pp. 191-200
    • Zhang, Q.X.1    Melnikov, Z.2    Feierman, D.E.3
  • 19
    • 15544372202 scopus 로고    scopus 로고
    • Autoantibodies and autoantigens in autoimmune hepatitis: Important tools in clinical practice and to study pathogenesis of the disease
    • Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004; 1:2.
    • (2004) J Autoimmune Dis , vol.1 , pp. 2
    • Zachou, K.1    Rigopoulou, E.2    Dalekos, G.N.3
  • 21
    • 5444243356 scopus 로고    scopus 로고
    • Expression and distribution of mu opioid receptors in the inner ear of the rat
    • Popper P, Cristobal R, Wackym PA. Expression and distribution of mu opioid receptors in the inner ear of the rat. Neuroscience 2004; 129:225-233.
    • (2004) Neuroscience , vol.129 , pp. 225-233
    • Popper, P.1    Cristobal, R.2    Wackym, P.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.